Additional Development. Company acknowledges that it will be solely responsible, after the completion of the Research Program, for further clinical development and, if commercially feasible, commercialization of the Product, including obtaining all regulatory approvals.
Appears in 3 contracts
Sources: Definitive Agreement, Definitive Agreement (Celator Pharmaceuticals Inc), Definitive Agreement (Celator Pharmaceuticals Inc)